JP2023539336A5 - - Google Patents
Info
- Publication number
- JP2023539336A5 JP2023539336A5 JP2023514050A JP2023514050A JP2023539336A5 JP 2023539336 A5 JP2023539336 A5 JP 2023539336A5 JP 2023514050 A JP2023514050 A JP 2023514050A JP 2023514050 A JP2023514050 A JP 2023514050A JP 2023539336 A5 JP2023539336 A5 JP 2023539336A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- disorders
- tetrahydro
- pyridine
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013558.8 | 2020-08-28 | ||
| GBGB2013558.8A GB202013558D0 (en) | 2020-08-28 | 2020-08-28 | GRP52 Modularor compounds |
| PCT/GB2021/052247 WO2022043714A1 (en) | 2020-08-28 | 2021-08-31 | Gpr52 modulator compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023539336A JP2023539336A (ja) | 2023-09-13 |
| JP2023539336A5 true JP2023539336A5 (enExample) | 2024-09-06 |
| JP7761635B2 JP7761635B2 (ja) | 2025-10-28 |
| JP7761635B6 JP7761635B6 (ja) | 2025-11-27 |
Family
ID=72749711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514050A Active JP7761635B6 (ja) | 2020-08-28 | 2021-08-31 | Ｇｐｒ５２モジュレーター化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230348416A1 (enExample) |
| EP (1) | EP4204408A1 (enExample) |
| JP (1) | JP7761635B6 (enExample) |
| KR (1) | KR20230058132A (enExample) |
| CN (1) | CN116507622B (enExample) |
| AU (1) | AU2021330379A1 (enExample) |
| BR (1) | BR112023003696A2 (enExample) |
| CA (1) | CA3193487A1 (enExample) |
| GB (1) | GB202013558D0 (enExample) |
| IL (1) | IL301007B2 (enExample) |
| MX (1) | MX2023002389A (enExample) |
| WO (1) | WO2022043714A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202003668D0 (en) | 2020-03-13 | 2020-04-29 | Heptares Therapeutics Ltd | GPR52 Modulator compounds |
| EP4139284A1 (en) | 2020-04-22 | 2023-03-01 | Neurocrine Biosciences, Inc. | Gpr52 modulators and methods of use |
| CN122555695A (zh) * | 2023-11-29 | 2026-08-11 | 爱克堤欧生物科学股份有限公司 | 可用作kcnt1抑制剂的杂环化合物 |
| CN121313618B (zh) * | 2025-12-09 | 2026-07-21 | 杭州师范大学附属医院(杭州市第二人民医院) | 丙酸在制备治疗肝豆状核变性肠肝轴紊乱的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX373876B (es) * | 2015-04-29 | 2020-03-26 | Arena Pharm Inc | 1-heteroaril-indolin-4-carboxamidas como moduladores de gpr52 útiles para el tratamiento o prevención de trastornos relacionados a las mismas. |
| WO2017077280A1 (en) * | 2015-11-02 | 2017-05-11 | Sonia Lain | Tetrahydroindazoles and medical uses thereof |
| WO2021009003A1 (en) * | 2019-07-16 | 2021-01-21 | Universität Hamburg | Computer-based identification of types in the empirical sciences by tangle theory |
| CN114650992A (zh) * | 2019-11-08 | 2022-06-21 | 赫普泰雅治疗有限公司 | Gpr52调节剂化合物 |
-
2020
- 2020-08-28 GB GBGB2013558.8A patent/GB202013558D0/en not_active Ceased
-
2021
- 2021-08-31 MX MX2023002389A patent/MX2023002389A/es unknown
- 2021-08-31 KR KR1020237010457A patent/KR20230058132A/ko active Pending
- 2021-08-31 WO PCT/GB2021/052247 patent/WO2022043714A1/en not_active Ceased
- 2021-08-31 JP JP2023514050A patent/JP7761635B6/ja active Active
- 2021-08-31 EP EP21769501.4A patent/EP4204408A1/en active Pending
- 2021-08-31 BR BR112023003696A patent/BR112023003696A2/pt unknown
- 2021-08-31 CN CN202180073276.0A patent/CN116507622B/zh active Active
- 2021-08-31 US US18/023,411 patent/US20230348416A1/en active Pending
- 2021-08-31 AU AU2021330379A patent/AU2021330379A1/en active Pending
- 2021-08-31 CA CA3193487A patent/CA3193487A1/en active Pending
-
2023
- 2023-02-28 IL IL301007A patent/IL301007B2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023519666A5 (enExample) | ||
| CA2237273C (en) | Angiogenesis inhibiting pyridazinamines | |
| HRP20241375T1 (hr) | Spojevi modulatora gpr52 | |
| CA2849169C (en) | Pyrazole carboxamides as janus kinase inhibitors | |
| JP2011515381A5 (enExample) | ||
| DK2576543T3 (en) | Pyrazole compounds as sigma receptor inhibitors | |
| JP2019536785A5 (enExample) | ||
| CN1950351B (zh) | 适用作h3配体的3-或4-单取代酚及苯硫酚衍生物 | |
| JP2023503331A5 (enExample) | ||
| JP2022540432A5 (enExample) | ||
| ZA200609277B (en) | Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors | |
| JP2008534542A (ja) | オキサゾール部分又はチアゾール部分を含む化合物、それらの製造方法及びそれらの使用 | |
| KR20180032645A (ko) | Ror 감마 조절제로서의 신규한 화합물 | |
| JP6345664B2 (ja) | 新規ｐｄｅ４阻害剤 | |
| CA2422923A1 (en) | Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity | |
| JP2022540586A5 (enExample) | ||
| JP2011153144A (ja) | 置換ピラゾール化合物 | |
| AU2009274355A1 (en) | Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as FAAH enzyme inhibitors | |
| JP2025503502A5 (enExample) | ||
| CA2780905A1 (en) | Azocyclic inhibitors of fatty acid amide hydrolase | |
| JP2014523400A (ja) | 芳香族アミド類およびそれらの使用 | |
| JP6272910B2 (ja) | 新規な細菌体密度感知制御剤及びその医療用途 | |
| JP2004518742A (ja) | 化学化合物 | |
| JP2017513825A5 (enExample) | ||
| JP2012508785A (ja) | アルキル−複素環のカルバメート誘導体、これらの調製およびこれらの使用 |